Emergências e Terapia Intensiva
Série de revisões | Artigos selecionados do Annual Update in Intensive Care and Emergency Medicine 2022.
29 Mar, 2022 | 14:25hPágina principal: Selected articles from the Annual Update in Intensive Care and Emergency Medicine 2022 – Critical Care
Vasopressor choice and timing in vasodilatory shock
Brain injury biomarkers for predicting outcome after cardiac arrest
The importance of neuromonitoring in non-brain injured patients
Artificial intelligence in critical care medicine
Artificial intelligence in infection management in the ICU
Sepsis performance improvement programs: from evidence towards clinical implementation
How to prolong filter life during continuous renal replacement therapy?
Immunomodulation by tetracyclines in the critically ill: an emerging treatment option?
The role of mitochondria in the immune response in critical illness
Estudo de coorte | Coinfecção SARS-CoV-2 e influenza, vírus sincicial respiratório ou adenovírus está associada com mortalidade aumentada.
29 Mar, 2022 | 14:20hComentário: Patients with Covid and flu double the risk of dying, say scientists – The Guardian
Comentário do autor no Twitter (fio – clique para saber mais)
In our latest paper from ISARIC4C we show that covid and flu together is a dangerous combination: 4x greater odds of needing a ventilator; 2x greater odds of dying. So we should test more widely for flu, and if you are offered a vaccine, please take it https://t.co/gI2GQnTRQH
— Kenneth Baillie (@kennethbaillie) March 25, 2022
Há evidência de dados fabricados em um estudo sobre vitamina C publicado na revista CHEST?
29 Mar, 2022 | 14:17hEvidence of Fabricated Data in a Vitamin C trial by Paul E Marik et al in CHEST – This Scattrd Corn
Comentário no Twitter (fio – clique para saber mais)
Remember that Vitamin C cures sepsis paper that could never be replicated in 9 RCTs?
Turns out there is a good reason why: it’s very likely fraudulent.
More brilliant statistical sleuthing by @K_Sheldrick.https://t.co/eCayYZyeGo
1/— Nick Mark MD (@nickmmark) March 22, 2022
Estudo randomizado | Em pacientes imunocomprometidos críticos com insuficiência respiratória aguda, os desfechos foram similares com o uso de oxigênio nasal de alto fluxo vs. alternância com ventilação não invasiva.
29 Mar, 2022 | 14:02hHigh-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial – The Lancet Respiratory Medicine (necessário cadastro gratuito)
Comentário no Twitter
NEW Research—In critically ill immunocompromised patients with acute respiratory failure, the mortality rate did not differ between HFNO alone and NIV alternating with HFNO
FLORALI-IM study from Rémi Coudroy & co https://t.co/xSJfQ9yTCt
Presented today at @ISICEM #ISICEM2022 pic.twitter.com/ooHnRcVnFV
— The Lancet Respiratory Medicine (@LancetRespirMed) March 22, 2022
M-A | Mortalidade da bacteriemia por Staphylococcus aureus.
25 Mar, 2022 | 15:31hEstudo randomizado | Tratamento com dose única de anfotericina B lipossomal para meningite por criptococo.
25 Mar, 2022 | 15:01hSingle-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
Cryptococcal meningitis is a major complication of HIV infection. Single-dose liposomal amphotericin B combined with flucytosine and fluconazole was noninferior to the WHO-recommended treatment and was associated with fewer adverse events. https://t.co/cg9DqSDhyN pic.twitter.com/SrKx4tDaph
— NEJM (@NEJM) March 23, 2022
Estudo randomizado | Posição prona em pacientes não intubados não melhorou os desfechos em pacientes com hipoxemia moderada relacionada à Covid-19.
25 Mar, 2022 | 14:58hEditorial: Awake prone positioning for patients with covid-19
Comunicado de imprensa: Lying prone long enough to improve outcomes is difficult for many covid-19 patients – BMJ
Revisão sistemática | Efetividade e segurança da oximetria de pulso no monitoramento remoto de pacientes com COVID-19.
25 Mar, 2022 | 14:54hComentários:
Simple home oxygen monitors signal when to seek COVID care – CIDRAP
Estudo randomizado | Entre pacientes críticos com Covid-19, o tratamento com um agente antiplaquetário teve pouca propensão a melhorar os dias sem suporte de órgão em 21 dias.
24 Mar, 2022 | 12:33hEditorial: Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status – JAMA
Comentário: Aspirin may improve 3-month survival for patients critically ill with COVID-19 – Imperial College London
Comentários no Twitter
In this bayesian randomized clinical trial, among critically ill patients with #COVID19, there was a low likelihood that treatment with an antiplatelet agent provided improvement in organ support–free days within 21 days. https://t.co/CnyWoOTn3Q
— JAMA (@JAMA_current) March 22, 2022
Diretriz científica AHA | Compreensão sobre a importância da experiência dos voluntários na parada cardíaca fora do hospital.
23 Mar, 2022 | 12:06hComunicado de imprensa: Lay rescuers who do CPR are heroes and survivors, new statement addresses their perspective – American Heart Association
Comentário: AHA News: CPR ‘Heroes’ Need More Support, Report Says – HealthDay